RenovoRx

RenovoRx(RNXT)

MOUNTAIN VIEW, CA
Medical Devices1 H-1B visas (FY2023)

Focus: Catheters

RenovoRx is a life sciences company focused on Catheters.

Oncology
Funding Stage
PUBLIC
Open Jobs
7

Pipeline & Clinical Trials

RenovoCath™ R120 Catheter
Pancreatic Neoplasms
N/A
Clinical Trials (1)
NCT02591082Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter
N/A
RenovoCath®
Solid Tumors
N/A
Clinical Trials (1)
NCT06805461PanTheR Registry Trial
N/A
Gemcitabine, local delivery
Pancreatic Cancer
Phase 1
Clinical Trials (1)
NCT02237157A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
Phase 1
Clinical Trials (1)
NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Phase 3

Open Jobs (7)

Interview Prep Quick Facts
Portfolio: 4 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 7 active jobs

Financials (FY2024)

Revenue
$43K
R&D Spend
$6M(13179%)32%
Net Income
-$10M
Cash
$1M

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub